Michele Yang

High Impact

Researcher

University of Arkansas for Medical Sciences

faculty

26 h-index 74 pubs 2,686 cited

Research Areas

Neurological disorders and treatments Muscle Physiology and Disorders Genomics and Rare Diseases Child and Adolescent Health Pharmacological Effects and Toxicity Studies Metabolism and Genetic Disorders Telemedicine and Telehealth Implementation COVID-19 Clinical Research Studies

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Michele Yang is a faculty member at the University of Arkansas for Medical Sciences, with a research focus on neurological and musculoskeletal disorders, particularly in pediatric populations. Her work investigates the efficacy and safety of therapeutic interventions, such as the drug Vamorolone, for conditions like Duchenne muscular dystrophy. Yang has also explored the genetic underpinnings of neurodevelopmental disorders, including research on loss-of-function mutations in the GEMIN5 gene. Her publications address critical aspects of patient care during the COVID-19 pandemic, including the risk of emergency room admissions following telemedicine visits and the development of consensus recommendations for gene therapy delivery in Duchenne muscular dystrophy patients.

Further research by Yang examines the identification of circulating protein biomarkers in Duchenne muscular dystrophy and the psychometric evaluation of questionnaires for conditions like Bardet-Biedl Syndrome. She has also contributed to the understanding of spinal muscular atrophy, including case studies on treatment with nusinersen. Yang's scholarship metrics include an h-index of 26 and over 2,600 citations across 74 publications, designating her as a highly cited researcher. She leads a research group and collaborates with other researchers, including Aravindhan Veerapandiyan at the University of Arkansas for Medical Sciences.